EXEL
Price
$46.15
Change
+$1.85 (+4.18%)
Updated
Jul 3 closing price
Capitalization
12.08B
39 days until earnings call
VOR
Price
$1.91
Change
+$0.46 (+31.72%)
Updated
Jul 3 closing price
Capitalization
238.67M
34 days until earnings call
Interact to see
Advertisement

EXEL vs VOR

Header iconEXEL vs VOR Comparison
Open Charts EXEL vs VORBanner chart's image
Exelixis
Price$46.15
Change+$1.85 (+4.18%)
Volume$6.04M
Capitalization12.08B
Vor Biopharma
Price$1.91
Change+$0.46 (+31.72%)
Volume$24.49M
Capitalization238.67M
EXEL vs VOR Comparison Chart in %
Loading...
EXEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VOR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EXEL vs. VOR commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EXEL is a Buy and VOR is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 04, 2025
Stock price -- (EXEL: $46.15 vs. VOR: $1.91)
Brand notoriety: EXEL: Notable vs. VOR: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EXEL: 167% vs. VOR: 121%
Market capitalization -- EXEL: $12.08B vs. VOR: $238.67M
EXEL [@Biotechnology] is valued at $12.08B. VOR’s [@Biotechnology] market capitalization is $238.67M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EXEL’s FA Score shows that 2 FA rating(s) are green whileVOR’s FA Score has 0 green FA rating(s).

  • EXEL’s FA Score: 2 green, 3 red.
  • VOR’s FA Score: 0 green, 5 red.
According to our system of comparison, EXEL is a better buy in the long-term than VOR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EXEL’s TA Score shows that 4 TA indicator(s) are bullish while VOR’s TA Score has 5 bullish TA indicator(s).

  • EXEL’s TA Score: 4 bullish, 3 bearish.
  • VOR’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both EXEL and VOR are a good buy in the short-term.

Price Growth

EXEL (@Biotechnology) experienced а +7.10% price change this week, while VOR (@Biotechnology) price change was +114.61% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

EXEL is expected to report earnings on Aug 12, 2025.

VOR is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EXEL($12.1B) has a higher market cap than VOR($239M). VOR YTD gains are higher at: 72.072 vs. EXEL (38.589). EXEL has higher annual earnings (EBITDA): 844M vs. VOR (-118.74M). EXEL has more cash in the bank: 1.03B vs. VOR (60M). VOR has less debt than EXEL: VOR (30.8M) vs EXEL (187M). EXEL has higher revenues than VOR: EXEL (2.3B) vs VOR (0).
EXELVOREXEL / VOR
Capitalization12.1B239M5,063%
EBITDA844M-118.74M-711%
Gain YTD38.58972.07254%
P/E Ratio20.23N/A-
Revenue2.3B0-
Total Cash1.03B60M1,718%
Total Debt187M30.8M607%
FUNDAMENTALS RATINGS
EXEL: Fundamental Ratings
EXEL
OUTLOOK RATING
1..100
4
VALUATION
overvalued / fair valued / undervalued
1..100
73
Overvalued
PROFIT vs RISK RATING
1..100
19
SMR RATING
1..100
32
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
93
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
EXELVOR
RSI
ODDS (%)
Bearish Trend 1 day ago
67%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
72%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
69%
Bullish Trend 1 day ago
81%
MACD
ODDS (%)
Bullish Trend 1 day ago
74%
N/A
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
66%
Bullish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
66%
Bullish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 1 day ago
65%
Bullish Trend 1 day ago
80%
Declines
ODDS (%)
Bearish Trend 8 days ago
63%
Bearish Trend 21 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
61%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
N/A
Bullish Trend 1 day ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
EXEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VOR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
PFI57.050.90
+1.60%
Invesco Dorsey Wright Financial Momt ETF
HYGI27.310.19
+0.72%
iShares Inflation Hedged Hgh Yld Bd ETF
UYLD51.10-0.01
-0.01%
Angel Oak UltraShort Income ETF
CADCHF0.58-0.00
-0.08%
Canadian Dollar - Switzerland Franc
IMTB43.29-0.08
-0.18%
iShares Core 5-10 Year USD Bond ETF

EXEL and

Correlation & Price change

A.I.dvisor indicates that over the last year, EXEL has been loosely correlated with JAZZ. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if EXEL jumps, then JAZZ could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EXEL
1D Price
Change %
EXEL100%
+4.18%
JAZZ - EXEL
35%
Loosely correlated
-0.43%
ALNY - EXEL
34%
Loosely correlated
+0.65%
TECH - EXEL
33%
Poorly correlated
-0.08%
MRSN - EXEL
32%
Poorly correlated
+3.50%
ORMP - EXEL
32%
Poorly correlated
+0.93%
More

VOR and

Correlation & Price change

A.I.dvisor indicates that over the last year, VOR has been loosely correlated with MDGL. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if VOR jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VOR
1D Price
Change %
VOR100%
+31.72%
MDGL - VOR
42%
Loosely correlated
-0.43%
TOVX - VOR
42%
Loosely correlated
-1.56%
ORMP - VOR
38%
Loosely correlated
+0.93%
IBIO - VOR
37%
Loosely correlated
+0.14%
QSI - VOR
36%
Loosely correlated
+8.08%
More